|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
Chains A, B:
E.C.?
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
Mol Cell
10:573-584
(2002)
|
|
PubMed id:
|
|
|
|
|
| |
|
ICAT inhibits beta-catenin binding to Tcf/Lef-family transcription factors and the general coactivator p300 using independent structural modules.
|
|
D.L.Daniels,
W.I.Weis.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
In the canonical Wnt signaling pathway, beta-catenin activates target genes
through its interactions with Tcf/Lef-family transcription factors and
additional transcriptional coactivators. The crystal structure of ICAT, an
inhibitor of beta-catenin-mediated transcription, bound to the armadillo repeat
domain of beta-catenin, has been determined. ICAT contains an N-terminal
helilical domain that binds to repeats 11 and 12 of beta-catenin, and an
extended C-terminal region that binds to repeats 5-10 in a manner similar to
that of Tcfs and other beta-catenin ligands. Full-length ICAT dissociates
complexes of beta-catenin, Lef-1, and the transcriptional coactivator p300,
whereas the helical domain alone selectively blocks binding to p300. The
C-terminal armadillo repeats of beta-catenin may be an attractive target for
compounds designed to disrupt aberrant beta-catenin-mediated transcription
associated with various cancers.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 2.
Figure 2. The ICAT Helical Domain(A) Structure of the
helical domain showing key hydrophobic core packing
interactions. Helices A, B, and C are indicated.(B) Hydrophobic
interactions between helix A and residues of β-catenin. The
color scheme is the same as Figure 1B, with β-catenin arm
repeats 11 and 12 termed R11 and R12, respectively. Side chains
from each protein that participate in hydrophobic interactions
are shown. Also shown is the superposition of the region II
helix of E-cadherin (Huber and Weis, 2001) (yellow; residue
numbers shown in parentheses). The superposition was performed
as described in Figure 1C. The hydrogen bond between Tyr 654 of
β-catenin and Asp 665 of E-cadherin is shown with a solid
line.(C) Electrostatic interactions (dashed lines) of ICAT
glutamate residues 37, 38, and 39 with arginine residues in
β-catenin or within ICAT, labeled as in (B). Mutation of these
three residues to alanine abolishes ICAT binding to β-catenin.
|
 |
Figure 5.
Figure 5. Model of ICAT as a Bipartite Transcriptional
InhibitorOn the left, transcription activation complexes
consisting of β-catenin, Tcf/Lef, and CBP/p300 are bound to
cognate DNA sites through interaction of the Tcf/Lef HMG box.
Binding of ICAT to β-catenin simultaneously displaces CBP/p300
and Tcf/Lef, allowing for Groucho/TLE repressor proteins to bind
to Tcf/Lef.
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from Cell Press:
Mol Cell
(2002,
10,
573-584)
copyright 2002.
|
|
| |
Figures were
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
P.Shanmugam,
A.J.Valente,
S.D.Prabhu,
B.Venkatesan,
T.Yoshida,
P.Delafontaine,
and
B.Chandrasekar
(2011).
Angiotensin-II type 1 receptor and NOX2 mediate TCF/LEF and CREB dependent WISP1 induction and cardiomyocyte hypertrophy.
|
| |
J Mol Cell Cardiol,
50,
928-938.
|
 |
|
|
|
|
 |
S.Mokhtarzada,
C.Yu,
A.Brickenden,
and
W.Y.Choy
(2011).
Structural characterization of partially disordered human chibby: insights into its function in the wnt-signaling pathway.
|
| |
Biochemistry,
50,
715-726.
|
 |
|
|
|
|
 |
A.S.Flozak,
A.P.Lam,
S.Russell,
M.Jain,
O.N.Peled,
K.A.Sheppard,
R.Beri,
G.M.Mutlu,
G.R.Budinger,
and
C.J.Gottardi
(2010).
Beta-catenin/T-cell factor signaling is activated during lung injury and promotes the survival and migration of alveolar epithelial cells.
|
| |
J Biol Chem,
285,
3157-3167.
|
 |
|
|
|
|
 |
P.M.Evans,
X.Chen,
W.Zhang,
and
C.Liu
(2010).
KLF4 interacts with beta-catenin/TCF4 and blocks p300/CBP recruitment by beta-catenin.
|
| |
Mol Cell Biol,
30,
372-381.
|
 |
|
|
|
|
 |
Q.Yu,
A.Sharma,
and
J.M.Sen
(2010).
TCF1 and beta-catenin regulate T cell development and function.
|
| |
Immunol Res,
47,
45-55.
|
 |
|
|
|
|
 |
A.J.Chien,
W.H.Conrad,
and
R.T.Moon
(2009).
A Wnt survival guide: from flies to human disease.
|
| |
J Invest Dermatol,
129,
1614-1627.
|
 |
|
|
|
|
 |
H.J.Choi,
J.C.Gross,
S.Pokutta,
and
W.I.Weis
(2009).
Interactions of plakoglobin and beta-catenin with desmosomal cadherins: basis of selective exclusion of alpha- and beta-catenin from desmosomes.
|
| |
J Biol Chem,
284,
31776-31788.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
K.M.Cadigan,
and
M.Peifer
(2009).
Wnt signaling from development to disease: insights from model systems.
|
| |
Cold Spring Harbor Perspect Biol,
1,
a002881.
|
 |
|
|
|
|
 |
R.Mo,
T.L.Chew,
M.T.Maher,
G.Bellipanni,
E.S.Weinberg,
and
C.J.Gottardi
(2009).
The terminal region of beta-catenin promotes stability by shielding the Armadillo repeats from the axin-scaffold destruction complex.
|
| |
J Biol Chem,
284,
28222-28231.
|
 |
|
|
|
|
 |
Z.Li,
M.Q.Hassan,
M.Jafferji,
R.I.Aqeilan,
R.Garzon,
C.M.Croce,
A.J.van Wijnen,
J.L.Stein,
G.S.Stein,
and
J.B.Lian
(2009).
Biological functions of miR-29b contribute to positive regulation of osteoblast differentiation.
|
| |
J Biol Chem,
284,
15676-15684.
|
 |
|
|
|
|
 |
F.J.Staal,
T.C.Luis,
and
M.M.Tiemessen
(2008).
WNT signalling in the immune system: WNT is spreading its wings.
|
| |
Nat Rev Immunol,
8,
581-593.
|
 |
|
|
|
|
 |
F.Liu,
S.Kohlmeier,
and
C.Y.Wang
(2008).
Wnt signaling and skeletal development.
|
| |
Cell Signal,
20,
999.
|
 |
|
|
|
|
 |
M.Chen,
M.Zhu,
H.Awad,
T.F.Li,
T.J.Sheu,
B.F.Boyce,
D.Chen,
and
R.J.O'Keefe
(2008).
Inhibition of beta-catenin signaling causes defects in postnatal cartilage development.
|
| |
J Cell Sci,
121,
1455-1465.
|
 |
|
|
|
|
 |
M.Z.Hossain,
Q.Yu,
M.Xu,
and
J.M.Sen
(2008).
ICAT expression disrupts beta-catenin-TCF interactions and impairs survival of thymocytes and activated mature T cells.
|
| |
Int Immunol,
20,
925-935.
|
 |
|
|
|
|
 |
M.Zhu,
M.Chen,
M.Zuscik,
Q.Wu,
Y.J.Wang,
R.N.Rosier,
R.J.O'Keefe,
and
D.Chen
(2008).
Inhibition of beta-catenin signaling in articular chondrocytes results in articular cartilage destruction.
|
| |
Arthritis Rheum,
58,
2053-2064.
|
 |
|
|
|
|
 |
M.de la Roche,
J.Worm,
and
M.Bienz
(2008).
The function of BCL9 in Wnt/beta-catenin signaling and colorectal cancer cells.
|
| |
BMC Cancer,
8,
199.
|
 |
|
|
|
|
 |
S.Jessen,
B.Gu,
and
X.Dai
(2008).
Pygopus and the Wnt signaling pathway: a diverse set of connections.
|
| |
Bioessays,
30,
448-456.
|
 |
|
|
|
|
 |
T.A.Blauwkamp,
M.V.Chang,
and
K.M.Cadigan
(2008).
Novel TCF-binding sites specify transcriptional repression by Wnt signalling.
|
| |
EMBO J,
27,
1436-1446.
|
 |
|
|
|
|
 |
J.H.Mikesch,
B.Steffen,
W.E.Berdel,
H.Serve,
and
C.Müller-Tidow
(2007).
The emerging role of Wnt signaling in the pathogenesis of acute myeloid leukemia.
|
| |
Leukemia,
21,
1638-1647.
|
 |
|
|
|
|
 |
J.Li,
C.Sutter,
D.S.Parker,
T.Blauwkamp,
M.Fang,
and
K.M.Cadigan
(2007).
CBP/p300 are bimodal regulators of Wnt signaling.
|
| |
EMBO J,
26,
2284-2294.
|
 |
|
|
|
|
 |
J.Pannequin,
N.Delaunay,
M.Buchert,
F.Surrel,
J.F.Bourgaux,
J.Ryan,
S.Boireau,
J.Coelho,
A.Pélegrin,
P.Singh,
A.Shulkes,
M.Yim,
G.S.Baldwin,
C.Pignodel,
G.Lambeau,
P.Jay,
D.Joubert,
and
F.Hollande
(2007).
Beta-catenin/Tcf-4 inhibition after progastrin targeting reduces growth and drives differentiation of intestinal tumors.
|
| |
Gastroenterology,
133,
1554-1568.
|
 |
|
|
|
|
 |
M.Ritco-Vonsovici,
A.Ababou,
and
M.Horton
(2007).
Molecular plasticity of beta-catenin: new insights from single-molecule measurements and MD simulation.
|
| |
Protein Sci,
16,
1984-1998.
|
 |
|
|
|
|
 |
M.de la Roche,
and
M.Bienz
(2007).
Wingless-independent association of Pygopus with dTCF target genes.
|
| |
Curr Biol,
17,
556-561.
|
 |
|
|
|
|
 |
P.M.Evans,
W.Zhang,
X.Chen,
J.Yang,
K.K.Bhakat,
and
C.Liu
(2007).
Kruppel-like factor 4 is acetylated by p300 and regulates gene transcription via modulation of histone acetylation.
|
| |
J Biol Chem,
282,
33994-34002.
|
 |
|
|
|
|
 |
R.G.Garces,
W.Gillon,
and
E.F.Pai
(2007).
Atomic model of human Rcd-1 reveals an armadillo-like-repeat protein with in vitro nucleic acid binding properties.
|
| |
Protein Sci,
16,
176-188.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
A.Schepsky,
K.Bruser,
G.J.Gunnarsson,
J.Goodall,
J.H.Hallsson,
C.R.Goding,
E.Steingrimsson,
and
A.Hecht
(2006).
The microphthalmia-associated transcription factor Mitf interacts with beta-catenin to determine target gene expression.
|
| |
Mol Cell Biol,
26,
8914-8927.
|
 |
|
|
|
|
 |
G.J.Woodhead,
C.A.Mutch,
E.C.Olson,
and
A.Chenn
(2006).
Cell-autonomous beta-catenin signaling regulates cortical precursor proliferation.
|
| |
J Neurosci,
26,
12620-12630.
|
 |
|
|
|
|
 |
G.Thyssen,
T.H.Li,
L.Lehmann,
M.Zhuo,
M.Sharma,
and
Z.Sun
(2006).
LZTS2 is a novel beta-catenin-interacting protein and regulates the nuclear export of beta-catenin.
|
| |
Mol Cell Biol,
26,
8857-8867.
|
 |
|
|
|
|
 |
H.J.Choi,
A.H.Huber,
and
W.I.Weis
(2006).
Thermodynamics of beta-catenin-ligand interactions: the roles of the N- and C-terminal tails in modulating binding affinity.
|
| |
J Biol Chem,
281,
1027-1038.
|
 |
|
|
|
|
 |
J.E.Pongracz,
and
R.A.Stockley
(2006).
Wnt signalling in lung development and diseases.
|
| |
Respir Res,
7,
15.
|
 |
|
|
|
|
 |
J.E.Pongracz,
S.M.Parnell,
T.Jones,
G.Anderson,
and
E.J.Jenkinson
(2006).
Overexpression of ICAT highlights a role for catenin-mediated canonical Wnt signalling in early T cell development.
|
| |
Eur J Immunol,
36,
2376-2383.
|
 |
|
|
|
|
 |
J.Liu,
H.Wang,
Y.Zuo,
and
S.R.Farmer
(2006).
Functional interaction between peroxisome proliferator-activated receptor gamma and beta-catenin.
|
| |
Mol Cell Biol,
26,
5827-5837.
|
 |
|
|
|
|
 |
L.O'Driscoll,
J.McMorrow,
P.Doolan,
E.McKiernan,
J.P.Mehta,
E.Ryan,
P.Gammell,
H.Joyce,
N.O'Donovan,
N.Walsh,
and
M.Clynes
(2006).
Investigation of the molecular profile of basal cell carcinoma using whole genome microarrays.
|
| |
Mol Cancer,
5,
74.
|
 |
|
|
|
|
 |
S.Shah,
M.N.Islam,
S.Dakshanamurthy,
I.Rizvi,
M.Rao,
R.Herrell,
G.Zinser,
M.Valrance,
A.Aranda,
D.Moras,
A.Norman,
J.Welsh,
and
S.W.Byers
(2006).
The molecular basis of vitamin D receptor and beta-catenin crossregulation.
|
| |
Mol Cell,
21,
799-809.
|
 |
|
|
|
|
 |
W.Zhang,
X.Chen,
Y.Kato,
P.M.Evans,
S.Yuan,
J.Yang,
P.G.Rychahou,
V.W.Yang,
X.He,
B.M.Evers,
and
C.Liu
(2006).
Novel cross talk of Kruppel-like factor 4 and beta-catenin regulates normal intestinal homeostasis and tumor repression.
|
| |
Mol Cell Biol,
26,
2055-2064.
|
 |
|
|
|
|
 |
A.Caricasole,
A.Bakker,
A.Copani,
F.Nicoletti,
G.Gaviraghi,
and
G.C.Terstappen
(2005).
Two sides of the same coin: Wnt signaling in neurodegeneration and neuro-oncology.
|
| |
Biosci Rep,
25,
309-327.
|
 |
|
|
|
|
 |
A.Mansukhani,
D.Ambrosetti,
G.Holmes,
L.Cornivelli,
and
C.Basilico
(2005).
Sox2 induction by FGF and FGFR2 activating mutations inhibits Wnt signaling and osteoblast differentiation.
|
| |
J Cell Biol,
168,
1065-1076.
|
 |
|
|
|
|
 |
D.L.Daniels,
and
W.I.Weis
(2005).
Beta-catenin directly displaces Groucho/TLE repressors from Tcf/Lef in Wnt-mediated transcription activation.
|
| |
Nat Struct Mol Biol,
12,
364-371.
|
 |
|
|
|
|
 |
F.J.Staal,
and
H.C.Clevers
(2005).
WNT signalling and haematopoiesis: a WNT-WNT situation.
|
| |
Nat Rev Immunol,
5,
21-30.
|
 |
|
|
|
|
 |
G.Rawadi,
and
S.Roman-Roman
(2005).
Wnt signalling pathway: a new target for the treatment of osteoporosis.
|
| |
Expert Opin Ther Targets,
9,
1063-1077.
|
 |
|
|
|
|
 |
H.J.Dyson,
and
P.E.Wright
(2005).
Intrinsically unstructured proteins and their functions.
|
| |
Nat Rev Mol Cell Biol,
6,
197-208.
|
 |
|
|
|
|
 |
R.C.Tseng,
J.W.Chang,
F.J.Hsien,
Y.H.Chang,
C.F.Hsiao,
J.T.Chen,
C.Y.Chen,
Y.S.Jou,
and
Y.C.Wang
(2005).
Genomewide loss of heterozygosity and its clinical associations in non small cell lung cancer.
|
| |
Int J Cancer,
117,
241-247.
|
 |
|
|
|
|
 |
B.J.Thompson
(2004).
A complex of Armadillo, Legless, and Pygopus coactivates dTCF to activate wingless target genes.
|
| |
Curr Biol,
14,
458-466.
|
 |
|
|
|
|
 |
C.C.Milburn,
J.Boudeau,
M.Deak,
D.R.Alessi,
and
D.M.van Aalten
(2004).
Crystal structure of MO25 alpha in complex with the C terminus of the pseudo kinase STE20-related adaptor.
|
| |
Nat Struct Mol Biol,
11,
193-200.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
C.Y.Logan,
and
R.Nusse
(2004).
The Wnt signaling pathway in development and disease.
|
| |
Annu Rev Cell Dev Biol,
20,
781-810.
|
 |
|
|
|
|
 |
K.Satoh,
M.Kasai,
T.Ishidao,
K.Tago,
S.Ohwada,
Y.Hasegawa,
T.Senda,
S.Takada,
S.Nada,
T.Nakamura,
and
T.Akiyama
(2004).
Anteriorization of neural fate by inhibitor of beta-catenin and T cell factor (ICAT), a negative regulator of Wnt signaling.
|
| |
Proc Natl Acad Sci U S A,
101,
8017-8021.
|
 |
|
|
|
|
 |
T.Sekiya,
S.Adachi,
K.Kohu,
T.Yamada,
O.Higuchi,
Y.Furukawa,
Y.Nakamura,
T.Nakamura,
K.Tashiro,
S.Kuhara,
S.Ohwada,
and
T.Akiyama
(2004).
Identification of BMP and activin membrane-bound inhibitor (BAMBI), an inhibitor of transforming growth factor-beta signaling, as a target of the beta-catenin pathway in colorectal tumor cells.
|
| |
J Biol Chem,
279,
6840-6846.
|
 |
|
|
|
|
 |
B.Henderson
(2003).
Nuclear transport as a target for cancer therapies.
|
| |
Drug Discov Today,
8,
249.
|
 |
|
|
|
|
 |
M.Bienz,
and
H.Clevers
(2003).
Armadillo/beta-catenin signals in the nucleus--proof beyond a reasonable doubt?
|
| |
Nat Cell Biol,
5,
179-182.
|
 |
|
|
|
|
 |
M.Fasolini,
X.Wu,
M.Flocco,
J.Y.Trosset,
U.Oppermann,
and
S.Knapp
(2003).
Hot spots in Tcf4 for the interaction with beta-catenin.
|
| |
J Biol Chem,
278,
21092-21098.
|
 |
|
|
|
|
 |
M.Kanamori,
P.Sandy,
S.Marzinotto,
R.Benetti,
C.Kai,
Y.Hayashizaki,
C.Schneider,
and
H.Suzuki
(2003).
The PDZ protein tax-interacting protein-1 inhibits beta-catenin transcriptional activity and growth of colorectal cancer cells.
|
| |
J Biol Chem,
278,
38758-38764.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|
');
}
}
 |